Repair of damaged organs in vitro

Area of Science:

• Nephrology
• Regenerative Medicine
• Biomedical Engineering

Background:

• Ischemia-reperfusion injury significantly impacts kidney transplant outcomes.
• Current treatments for kidney injury focus on managing symptoms rather than promoting cellular repair.
• Ex vivo organ perfusion offers a platform for therapeutic interventions before transplantation.

Purpose of the Study:

• To investigate the efficacy of ex vivo, acellular, near-normothermic perfusion for delivering growth factors to ischemically damaged kidneys.
• To determine if this treatment can accelerate cellular recovery and ameliorate reperfusion injury.
• To explore the impact of growth factor administration on cellular metabolism and protein expression in damaged kidneys.

Main Methods:

• Developed an acellular, near-normothermic perfusion system for ex vivo kidney treatment.
• Administered growth factors to kidneys subjected to ischemia.
• Monitored oxidative metabolism and cellular processes during perfusion.
• Analyzed the expression of injury and repair proteins.

Main Results:

• Restored oxidative metabolism in ischemically damaged kidneys.
• Supported the up-regulation of cellular processes involved in repair.
• Demonstrated that growth factor delivery modulated injury and repair proteins.
• Observed cellular recovery and a reduction in cell death pathways.

Conclusions:

• Ex vivo growth factor administration can accelerate cellular recovery in ischemically damaged kidneys.
• Near-normothermic perfusion effectively delivers therapeutics to enhance kidney repair.
• This approach shows potential for ameliorating reperfusion injury and improving organ viability for transplantation.